Document Detail


Ramosetron for preventing postoperative nausea and vomiting in women undergoing gynecological surgery.
MedLine Citation:
PMID:  10648342     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
IMPLICATIONS: This randomized, double-blinded, placebo-controlled trial in 120 women found the effective dose of ramosetron for preventing postoperative nausea and vomiting after gynecological surgery to be 0.3 mg.
Authors:
Y Fujii; Y Saitoh; H Tanaka; H Toyooka
Publication Detail:
Type:  Clinical Trial; Journal Article; Randomized Controlled Trial; Retracted Publication    
Journal Detail:
Title:  Anesthesia and analgesia     Volume:  90     ISSN:  0003-2999     ISO Abbreviation:  Anesth. Analg.     Publication Date:  2000 Feb 
Date Detail:
Created Date:  2000-02-28     Completed Date:  2000-02-28     Revised Date:  2013-05-27    
Medline Journal Info:
Nlm Unique ID:  1310650     Medline TA:  Anesth Analg     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  472-5     Citation Subset:  AIM; IM    
Affiliation:
Department of Anesthesiology, University of Tsukuba Institute of Clinical Medicine, Tsukuba City, Japan.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Antiemetics / adverse effects,  therapeutic use*
Benzimidazoles / adverse effects,  therapeutic use*
Double-Blind Method
Female
Gynecologic Surgical Procedures*
Humans
Middle Aged
Postoperative Nausea and Vomiting / prevention & control*
Prospective Studies
Chemical
Reg. No./Substance:
0/Antiemetics; 0/Benzimidazoles; 7ZRO0SC54Y/ramosetron
Comments/Corrections
Retraction In:
Anesth Analg. 2013 Mar;116(3):745   [PMID:  23439830 ]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Inert gas exchange during pneumoperitoneum at incremental values of positive end-expiratory pressure...
Next Document:  Nondepolarizing neuromuscular blockers inhibit the serotonin-type 3A receptor expressed in Xenopus o...